Lv1
20 积分 2023-09-28 加入
Major bleeding with old and novel oral anticoagulants: How to manage it. Focus on general measures
2个月前
已完结
Oral Anticoagulant Use and Post-Fall Mortality in Long-Term Care Home Residents
2个月前
已关闭
A single-cell atlas of bone marrow B cells reveals defective central B-cell tolerance in immune thrombocytopenia
3个月前
已完结
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial
3个月前
已完结
An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct
4个月前
已完结
The new era of primary immune thrombocytopenia management in adults: A narrative review of current and emerging treatments
5个月前
已完结
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study
8个月前
已完结
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
8个月前
已完结
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors
8个月前
已完结
Immune thrombocytopenia in patients treated with immune checkpoint inhibitors
8个月前
已完结
皖公网安备34019202002308
